Table 2. Baseline characteristics, percent weight loss and interventional data in participants who achieved at least modest weight loss (≥ 3%) following the intervention compared to those that did not (<3%).
| Variable | No Weight loss (n = 126) | Weight loss (n = 37) |
|---|---|---|
| Age (yrs.) | 52.3 (6.4) | 52.9 (6.6) |
| Female (%), n | 44.4 (56) | 40.5 (15) |
| Race | ||
| Caucasian n (%) | 104 (82.5) | 32 (86.5) |
| African American n (%) | 14.3 (18) | 10.8 (4) |
| Hispanic n (%) | 2 (1.6) | 0 (0) |
| Asian n (%) | 2 (1.6) | 1 (0.6) |
| Weight (kg) | 87.7 (13.8) | 87.0 (14.0) |
| %Weight loss | -0.9 (1.9) | -5.3 (2.0) * |
| Waist circumference (natural) (cm) | 95.7 (10.1) | 96.1 (10.0) |
| Waist circumference (umbilicus) (cm) | 103.3 (10.1) | 102.4 (9.1) |
| Glucose (mg/dL) | 93.8 (9.5) | 92.7 (7.9) |
| Insulin (mIU/L) | 9.5 (6.3) | 8.6 (5.7) |
| HOMA-IR | 2.2 (1.5) | 2.0 (1.5) |
| Insulin sensitivity (mU·l-1 ·min -1) | 3.3 (2.2) | 3.9 (2.8) |
| AIRg (mU·l-1·min-1) | 459.6 (363.6) | 468.0 (402.8) |
| Sg (per min) | 0.018 (0.008) | 0.020 (0.008) |
| Low density lipoprotein (mg/dL) | 126.4 (24.4) | 128.0 (24.0) |
| High density lipoprotein (mg/dL) | 46.3 (14.3) | 45.6 (14.4) |
| Total cholesterol (mg/dL) | 197.7 (31.5) | 198.5 (30.0) |
| Triglycerides (mg/dL) | 156.5 (89.1) | 161.6 (94.4) |
| Non-HDL cholesterol (mg/dL) | 151.4 (27.6) | 153.0 (23.7) |
| Small LDL cholesterol (mg/dL) | 38.1 (33.9) | 39.2 (35.0) |
| Large HDL cholesterol (mg/dL) | 7.7 (7.4) | 7.3 (5.7) |
| LDL particles (mmol/L) | 1411.7 (348.7) | 1453.2 (341.0) |
| Low density lipoprotein particle size (nm) | 20.8 (0.9) | 20.7 (0.9) |
| High density lipoprotein particle size (nm) | 8.9 (0.4) | 8.8 (0.4) |
| VO2 max (ml.kg.min) | 28.4 (5.9) | 27.8 (5.2) |
| VO2 max (L/min) | 2.5 (0.7) | 2.5 (0.7) |
| Exercise time (minutes per week) | 174.4 (86.0) | 181.1 (92.0) |
| Exercise adherence (%) | 88.9% (0.7) | 95.2% (0.8) * |
Continuous variables are expressed in mean (SD) and categorical variables are expressed in (%), n
* Indicates significant difference compared to No weight loss condition. AIRg: Acute insulin response to glucose, Sg: Glucose effectiveness